Summary: A new study reveals how LMO1 works wih the MYCN gene to fuel the spread of neuroblastoma brain cancer.
Source: Mayo Clinic.
For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas.
Neuroblastoma is a cancer that most commonly affects children age 5 or younger, though it may rarely occur in older children. The cancer develops from immature nerve cells found in several areas of the body but most commonly arises in and around the adrenal glands, which have similar origins to nerve cells and sit atop the kidneys.
Like other cancers, neuroblastoma characteristics are linked to genetic alterations.
“Increased expression of the LMO1 gene is associated with aggressive, high-risk neuroblastomas,” says Shizhen Zhu, M.D., Ph.D., lead author on the paper and a biomedical researcher at Mayo Clinic. “Our genetic analyses using zebra fish demonstrates for the first time that LMO1 cooperates with the MYCN gene to accelerate tumor onset and increase tumor penetrance.”
Two strains of zebra fish, developed at Mayo Clinic’s Zebra Fish Facility, were engineered to express either LMO1 or MYCN at high levels.
“We developed the first zebra fish model of neuroblastoma metastasis to uncover the molecular mechanism underlying LMO1-mediated neuroblastoma spread, because this is a major problem in two-thirds of the children who have high-risk disease at diagnosis,” says Dr. Zhu.
As the authors report in the Cancer Cell paper, the two strains of zebra fish were interbred. In the fish expressing both MYCN and LMO1, the authors observed tumor development in 80 percent of the offspring by 24 weeks of age. In offspring expressing only the MYCN gene, tumors developed in only 20 to 30 percent during the same time period.
“This is the first evidence in an animal model that high levels of LMO1 expression promote metastasis of MYCN-induced neuroblastoma,” says Dr. Zhu. “The mechanism to account for this, according to our findings, is the dysregulation of genes associated with the extracellular matrix.”
The extracellular matrix is the material that exists between cells. It includes structural and chemical elements that link cells physically and in terms of communication. In zebra fish expressing both genes, markers of stiffness increased in the extracellular matrix. The authors suggest that high level of LMO1 expression changes expression of genes controlling the extracellular matrix. And that may, in turn, lead to alterations that benefit tumor growth and spread.
Knowing how LMO1 contributes to neuroblastoma aggression does not directly apply to patients today says Dr. Zhu. But she emphasizes that this zebra fish model is vital to address the unmet needs of patients in the future.
“Our zebra fish model of neuroblastoma with transgenic expression of LMO1 and MYCN should provide a valuable platform for evaluating the effects of drugs to prevent or inhibit neuroblastoma metastasis going forward,” says Dr. Zhu. Her laboratory is conducting follow-up studies based on the unique zebra fish model from this study to translate the knowledge into effective therapies.
About this neuroscience research article
Funding: The authors report no conflict of interest. Funding for this work was provided by many sources, including the National Cancer Institute, the U.S. Department of Defense, Mayo Clinic’s Center for Biomedical Discovery, Mayo Clinic Cancer Center, and Mayo Clinic’s Center for Individualized Medicine. A full list of funding support appears in the publication.
Source: Sara Tiner – Mayo Clinic
Image Source: NeuroscienceNews.com image is adapted from the Mayo Clinic news release.
Original Research: Abstract for “LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis” by Shizhen Zhu, Xiaoling Zhang, Nina Weichert-Leahey, Zhiwei Dong, Cheng Zhang, Gonzalo Lopez, Ting Tao, Shuning He, Andrew C. Wood, Derek Oldridge, Choong Yong Ung, Janine H. van Ree, Amish Khan, Brittany M. Salazar, Edroaldo Lummertz da Rocha, Mark W. Zimmerman, Feng Guo, Hong Cao, Xiaonan Hou, S. John Weroha, Antonio R. Perez-Atayde, Donna S. Neuberg, Alexander Meves, Mark A. McNiven, Jan M. van Deursen, Hu Li, John M. Maris, and A. Thomas Look in Cancer Cell. Published online August 31 2017 doi:10.1016/j.ccell.2017.08.002
Cite This NeuroscienceNews.com Article
Mayo Clinic “Genes Fueling Neuroblastoma Spread Identified.” NeuroscienceNews. NeuroscienceNews, 4 September 2017.
Mayo Clinic (2017, September 4). Genes Fueling Neuroblastoma Spread Identified. NeuroscienceNew. Retrieved September 4, 2017 from http://neurosciencenews.com/genetics-neuroblastoma-spread-7410/
Mayo Clinic “Genes Fueling Neuroblastoma Spread Identified.” http://neurosciencenews.com/genetics-neuroblastoma-spread-7410/ (accessed September 4, 2017).
LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis
•Coexpression of LMO1 with MYCN promotes neuroblastomagenesis
•Transgenic expression of LMO1 promotes neuroblastoma metastasis in vivo
•Increased LMO1 expression enhances neuroblastoma cell invasion and migration
•Increased LMO1 expression upregulates genes affecting tumor cell-matrix interactions
A genome-wide association study identified LMO1, which encodes an LIM-domain-only transcriptional cofactor, as a neuroblastoma susceptibility gene that functions as an oncogene in high-risk neuroblastoma. Here we show that dβh promoter-mediated expression of LMO1 in zebrafish synergizes with MYCN to increase the proliferation of hyperplastic sympathoadrenal precursor cells, leading to a reduced latency and increased penetrance of neuroblastomagenesis. The transgenic expression of LMO1 also promoted hematogenous dissemination and distant metastasis, which was linked to neuroblastoma cell invasion and migration, and elevated expression levels of genes affecting tumor cell-extracellular matrix interaction, including loxl3, itga2b, itga3, and itga5. Our results provide in vivo validation of LMO1 as an important oncogene that promotes neuroblastoma initiation, progression, and widespread metastatic dissemination.
“LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis” by Shizhen Zhu, Xiaoling Zhang, Nina Weichert-Leahey, Zhiwei Dong, Cheng Zhang, Gonzalo Lopez, Ting Tao, Shuning He, Andrew C. Wood, Derek Oldridge, Choong Yong Ung, Janine H. van Ree, Amish Khan, Brittany M. Salazar, Edroaldo Lummertz da Rocha, Mark W. Zimmerman, Feng Guo, Hong Cao, Xiaonan Hou, S. John Weroha, Antonio R. Perez-Atayde, Donna S. Neuberg, Alexander Meves, Mark A. McNiven, Jan M. van Deursen, Hu Li, John M. Maris, and A. Thomas Look in Cancer Cell. Published online August 31 2017 doi:10.1016/j.ccell.2017.08.002
Feel free to share this Neuroscience News.